RNA Biology · 2020 · 54 citations · 39 references
MedicineCell BiologyOncologyCell SignalingMolecular OncologySignal TransductionCancer Cell SignalingCell Signaling NetworksEpithelial-mesenchymal TransitionOncogenic Signaling PathwaysOvarian CancerSignal Transduction In CancerCancer Signaling PathwaysDisassemblyEpithelial-mesenchymal Transition In CancerErk SignalingExtracellular Signal-regulated Kinase PathwayHigh-grade Serous Ovarian CarcinomaPost-transcriptional RegulationSrc Family Activation
Epithelial-to-mesenchymal transition (EMT) is a hallmark of aggressive, mesenchymal-like high-grade serous ovarian carcinoma (HGSOC). The SRC kinase is a key driver of cancer-associated EMT promoting adherens junction (AJ) disassembly by phosphorylation-driven internalization and degradation of AJ proteins. Here, we show that the IGF2 mRNA-binding protein 1 (IGF2BP1) is up-regulated in mesenchymal-like HGSOC and promotes SRC activation by a previously unknown protein-ligand-induced, but RNA-independent mechanism. IGF2BP1-driven invasive growth of ovarian cancer cells essentially relies on the SRC-dependent disassembly of AJs. Concomitantly, IGF2BP1 enhances ERK2 expression in an RNA-binding dependent manner. Together this reveals a post-transcriptional mechanism of interconnected stimulation of SRC/ERK signalling in ovarian cancer cells. The IGF2BP1-SRC/ERK2 axis is targetable by the SRC-inhibitor saracatinib and MEK-inhibitor selumetinib. However, due to IGF2BP1-directed stimulation, only combinatorial treatment effectively overcomes the IGF2BP1-promoted invasive growth in 3D culture conditions as well as intraperitoneal mouse models. In conclusion, we reveal an unexpected role of IGF2BP1 in enhancing SRC/MAPK-driven invasive growth of ovarian cancer cells. This provides a rationale for the therapeutic benefit of combinatorial SRC/MEK inhibition in mesenchymal-like HGSOC.
39
Integrated genomic analyses of ovarian carcinoma
Debra Bell, Andrew Berchuck, Narciso Olvera et al. · Nature · 2011 · 8.2K citations · Full text
Emerging landscape of oncogenic signatures across human cancers
Giovanni Ciriello, Martin L. Miller, Bülent Arman Aksoy et al. · Nature Genetics · 2013 · 1.5K citations · Full text
Medicine, Cancer Biology, Oncology +17